Posted inClinical Updates Gastroenterology
Dietary Intervention Lowers Intestinal Inflammation in High-Risk Relatives of Crohn’s Disease Patients: Insights from the PIONIR Trial
The PIONIR randomized crossover trial demonstrates that a specific Tasty&Healthy diet significantly reduces fecal calprotectin levels, a marker of gut inflammation, in first-degree relatives at high risk for Crohn's disease, suggesting potential for dietary prevention.



















